Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: Results from ANRS CO13 HEPAVIH

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 745-747

  Carrieri, M Patrizia ^a,b,c   Cohen, Julien ^a,b,c   Salmon Ceron, Dominique ^d   Winnock, Maria ^e  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d INSTITUT COCHIN   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ALERTNESS; ANGER; COFFEE; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEPRESSION; FATIGUE; FOLLOW UP; FOOD INTAKE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LOGISTIC REGRESSION ANALYSIS; MENTAL CONCENTRATION; MIXED INFECTION; NEUTROPHIL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK; SIDE EFFECT; THROMBOCYTE;

ADULT; ANTIVIRAL AGENTS; COFFEE; COINFECTION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; POLYETHYLENE GLYCOLS; QUESTIONNAIRES; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 84857357650     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.08.005     Document Type: Letter

References (10)

1. C.E. Costentin, F. Roudot-Thoraval, E.S. Zafrani, F. Medkour, J.M. Pawlotsky, and A. Mallat Association of caffeine intake and histological features of chronic hepatitis C J Hepatol 54 2011 1123 1129
2. F. Bravi, C. Bosetti, A. Tavani, V. Bagnardi, S. Gallus, and E. Negri Coffee drinking and hepatocellular carcinoma risk: a meta-analysis Hepatology 46 2007 430 435
3. N. Freedman, T. Curto, K. Lindsay, E. Wright, R. Sinha, and J. Everhart Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C Gastroenterology 140 2011 1961 1969
4. F. Marcellin, M. Preau, P. Dellamonica, I. Ravaux, P. Kurkdji, and C. Protopopescu Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects J Pain Symptom Manage 34 2007 413 421
5. F. Marcellin, M. Preau, I. Ravaux, P. Dellamonica, B. Spire, and M.P. Carrieri Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research HIV Clin Trials 8 2007 320 327
6. J.J. Weiss, N. Brau, A. Stivala, T. Swan, and D. Fishbein Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research Aliment Pharmacol Ther 30 2009 14 27
7. M.A. Heckman, J. Weil, and E. Gonzalez de Mejia Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters J Food Sci 75 2010 R77 R87
8. M.A. Loko, D. Salmon, P. Carrieri, M. Winnock, M. Mora, and L. Merchadou The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010 BMC Infect Dis 10 2011 303
9. A.C. Justice, W. Holmes, A.L. Gifford, L. Rabeneck, R. Zackin, and G. Sinclair Development and validation of a self-completed HIV symptom index J Clin Epidemiol 54 2001 S77 S90
10. M.P. Carrieri, V. Villes, F. Raffi, C. Protopopescu, M. Preau, and D. Salmon Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8) Int J Drug Policy 18 2007 288 295